Anzeige
Mehr »
Samstag, 26.07.2025 - Börsentäglich über 12.000 News

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A1W1LG | ISIN: IL0011224156 | Ticker-Symbol:
NASDAQ
25.07.25 | 21:59
1,065 US-Dollar
+8,12 % +0,080
Branche
Gesundheitswesen
Aktienmarkt
Sonstige
1-Jahres-Chart
ICECURE MEDICAL LTD Chart 1 Jahr
5-Tage-Chart
ICECURE MEDICAL LTD 5-Tage-Chart

Aktuelle News zur ICECURE MEDICAL Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
ICECURE MEDICAL Aktie jetzt für 0€ handeln
FrIceCure Medical Ltd. - 6-K, Report of foreign issuer2
10.07.IceCure Medical Ltd. - 6-K, Report of foreign issuer-
03.07.IceCure Medical Ltd. - F-1/A, Registration statement for certain foreign private issuers1
03.07.IceCure Medical Ltd. - 6-K, Report of foreign issuer1
03.07.IceCure Medical: IceCure Reports Preliminary Financial Results for the Three and Six Months Ended June 30, 202569CAESAREA, Israel, July 3, 2025 /PRNewswire/ -- IceCure Medical Ltd. (Nasdaq: ICCM) ("IceCure", "IceCure Medical" or the "Company"), developer of minimally-invasive...
► Artikel lesen
25.06.IceCure Medical Ltd. - 6-K, Report of foreign issuer-
25.06.IceCure Medical Ltd. - F-1/A, Registration statement for certain foreign private issuers1
16.06.IceCure Medical Ltd. - F-1, Registration statement for certain foreign private issuers3
09.06.IceCure Medical Ltd. - 6-K, Report of foreign issuer1
09.06.IceCure Medical: IceCure Receives Notice of Patent Allowance in U.S. for a Novel Cryogen Flow Control to Optimize Patient Outcomes130IceCure has 20+ patents in the U.S. and the Company anticipates further market traction upon FDA's marketing authorization decision in early-stage breast cancer ...
► Artikel lesen
30.05.H.C. Wainwright maintains Buy on IceCure Medical, target at $2.501
29.05.IceCure Medical GAAP EPS of -$0.06 beats by $0.01, revenue of $0.73M misses by $0.25M2
28.05.IceCure Medical Ltd Q1 Loss Decreases, Beats Estimates-
28.05.IceCure Medical GAAP EPS of -$0.06 beats by $0.02, revenue of $0.73M misses by $0.02M3
28.05.IceCure Medical Ltd. - 6-K, Report of foreign issuer1
28.05.IceCure Medical Reports First Quarter 2025 Financial Results108Recently finalized and delivered proposed post market study plan to the FDA; Awaiting marketing authorization decision for ProSense® in women aged 70+ with early-stage...
► Artikel lesen
27.05.Earnings Preview For Icecure Medical1
21.05.IceCure Medical Ltd. - 6-K, Report of foreign issuer2
30.04.IceCure Medical Ltd. - 6-K, Report of foreign issuer-
30.04.IceCure Medical: IceCure Announces Positive FDA Development: Understanding on Path Forward for Marketing Authorization of ProSense Cryoablation in Women 70+ with Early-Stage Breast Cancer106Final marketing authorization decision for early-stage breast cancer is expected upon the FDA's approval of IceCure's post-market study plan IceCure to engage...
► Artikel lesen
Weiter >>
50 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1